We spoke with Michael Singer, MD who provided an overview of his presentation and his work with Nanoscope Therapeutics, "MCO-010 Optogenetic Therapy to Treat Stargardt Disease: Safety and Efficacy through Week 48 in the Phase 2a STARLIGHT Clinical Trial."
Dr Ali Erginay of Lariboisière Hospital in Paris, France, discusses his EURETINA presentation, "Introducing optomap® Ultra-widefield Colour Red-Green-Blue Multimodal Imaging"
The data was presented in a poster titled at the American Thyroid Association (ATA).
Experts in the field weigh in on and give opinions on the question "What do you wish patients knew about eye health."
The collaboration will drive an effort to develop predictive analytics to enable early detection of eye diseases and more personalized treatments to prevent vision loss for people with serious eye diseases.
Steven A. Greenstein, MD, emphasizes the importance of identifying and assessing eye emergencies, highlighting the need to determine when to escalate care from primary to subspecialty settings. He discusses various types of anterior segment emergencies, while stressing the significance of maintaining a calm demeanor in these critical situations.
A subgroup analysis of the phase 3 PULSAR Trial showed robust increases in the best-corrected visual acuity (BCVA) compared with baseline at week 48.
Our team spoke to David Almeida, MD, PhD, MBA about his EURETINA presentation titled, The Real-World Efficacy and Safety of Faricimab in Neovascular AMD: The TRUCKEE Study.
Case 1 highlights the potential for this treatment for patients with dry AMD with noted letter gains
Robyn Guymer, MBBS, PhD, Deputy Director, Centre for Eye Research Australia, and Professor of Surgery (Ophthalmology), University of Melbourne, Australia, discussed the study findings at the 23rd annual Euretina Congress, Amsterdam.
Our team spoke to Varun Chaudhary, MD, about his EURETINA presentation, titled "Systematic Review and Metanalysis in Macular Hole RCTs – Posturing after Macular Hole Surgery."
An increase in sexually transmitted infections may be causing an increase in number of eye infections.
Experts in the field weigh in on and give opinions on the question "What do you wish patients knew about eye health."
Our team spoke to Varun Chaudhary, MD, about his EURETINA presentation, titled "Systematic Review and Metanalysis in Macular Hole RCTs – Posturing after Macular Hole Surgery"
For retinal specialists grappling with diseases once thought “untreatable,” gene therapies present a wide range of viable options
Experts in the field weigh in on and give opinions on the question "What do you wish patients knew about eye health."
Altris has advanced AI models to enable vendor-neutral retina layer segmentation as well as detection and visualization of more than 70 retina conditions such as dry and aet age-related macular degeneration, geographic atrophy, diabetic retinopathy, diabetic macular edema and central retinal vein occlusion.
Experts in the field weigh in on and give opinions on the question "What do you wish patients knew about eye health."
Laser scleral microporation rejuvenates dynamic range of focus by increasing scleral pliability, allowing underlying structures to move more freely
Experts in the field weigh in on and give opinions on the question "What do you wish patients knew about eye health."
Educating patients about the importance of consistent care is key.
A rapid lateral-flow device shows high sensitivity and specificity in identifying Aspergillus species in corneal samples, aiding in diagnosing microbial keratitis. The device, coupled with ratiometric analysis, proves robust and cost-effective, potentially revolutionizing MK diagnosis, especially in low-resource settings
Experts in the field weigh in on and give opinions on the question "What do you wish patients knew about eye health."
Results showed that the PAUL Glaucoma Implant is an effective glaucoma drainage device that provides effective IOP lowering, similar to that achieved with the Baerveldt Glaucoma Implant, but with lower rates of complications
The MyopiaX-1 trial studies MyopiaX, a smartphone application that aims to slow the progression of myopia, or nearsightedness, in children and adolescents.
Experts in the field weigh in on and give opinions on the question "What do you wish patients knew about eye health."
Experts in the field weigh in on and give opinions on the question "What do you wish patients knew about eye health."
Investigators note a supply shortage led to use of half a dose for imaging purposes.
In this EyePod® episode, David Hutton sits down with Shankar Musunuri, CEO of Ocugen to discuss updated data for OCU400.
